Article - 28 Apr 2005
The nasal mucosa provides an easily targeted site for drug delivery. The particle size delivered by nasal drug delivery devices is an important parameter in defining the drug deposition site within...
Article - 23 Feb 2019
This article discusses a new method of quantifying redispersion potential of Al salts in pharmaceutical vaccines.
News - 22 Oct 2015
In a webinar presentation entitled the ‘Application of DSC to structural studies on meningitis vaccines’, which is now freely available on the Malvern Panalytical’ website, Dr David Staunton,...
News - 10 Dec 2014
An injectable, programmable biomaterial that could fight and help prevent cancer, HIV and other infectious diseases has been developed by researchers belonging to Harvard University’s Wyss...
News - 26 Oct 2010
NanoBio Corporation today announced that company founder and chief executive officer James R. Baker, Jr. MD, will meet with renown scientists at the 6th Annual Grand Challenges in Global Health (GCGH)...
News - 11 Apr 2010
Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the...
Article - 11 May 2018
If you’re involved with the transportation or storage of vaccinations, then you’ll know that is of utmost importance to monitor the temperature at all times.
News - 14 May 2008
Researchers at Aerovax, working at the Massachusetts Institute of Technology (MIT) in the US, are using the Spraytec particle size analyzer from Malvern Instruments in the development of an innovative...
News - 22 Mar 2005
Research scientists in the Canadian biotechnology company ID Biomedical are using two Brookhaven 90Plus particle size analyzers to provide critical data towards the characterization of the innovative...
In this video, Professor Chad Mirkin from Northwestern University explains how spiracle nucleic acids (SNAs) can be used to create cancer vaccines. If someone has breast cancer, they begin to have...